IP Verse

Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof

Patent No. EP3597216 (titled "Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof") was filed by E R Squibb & Sons on Aug 11, 2009. The application was issued on Aug 24, 2022.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
APPLEYARD LEESMay 24, 2023APPLEYARD LEES
STRAWMANMay 24, 2023VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
REGENERON PHARMACEUTICALSMay 23, 2023HOFFMANN EITLE
KRAUS & WEISERTMay 19, 2023LADENDORF
KRAUS & WEISERTMay 19, 2023KRAUS & LEDERER PARTGMBB
MERCK SHARP & DOHMEApr 27, 2023ABITZ & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP3597216

E R SQUIBB & SONS
Application Number
EP19186310A
Filing Date
Aug 11, 2009
Status
Granted And Under Opposition
Jul 22, 2022
Publication Date
Aug 24, 2022
External Links
Slate, Register , Google Patents